Cardlytics, Inc.
DE ˙ DB ˙ US14161W1053
0,45 € ↓ -0,04 (-8,23%)
2026-06-05
DEL PRIS
SecurityDE:CYX / Cardlytics, Inc.
InstitutionRockefeller Capital Management L.P.
Latest Disclosed Ownership2,250 shares
Latest Disclosed Value $ 2,363
Rockefeller Capital Management L.P. ownership in CYX / Cardlytics, Inc.

On May 14, 2026 - Rockefeller Capital Management L.P. filed a 13F-HR form disclosing ownership of 2,250 shares of Cardlytics, Inc. (DE:CYX) valued at $1,666 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on March 16, 2026 disclosing 2,250 shares of Cardlytics, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $1,004 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F CARDLYTICS COM 14161W105 2,250 0 0.00 2 0.00 0.0000
2026-03-16 2025-12-31 13F/A-1 CARDLYTICS COM 14161W105 2,250 -3,400 -60.18 3 -84.62 0.0000
2026-02-14 2025-12-31 13F CARDLYTICS COM 14161W105 2,250 -3,400 3 0.0000
2025-11-14 2025-09-30 13F CARDLYTICS COM 14161W105 5,650 5,650 14 0.0000
2022-11-02 2022-09-30 13F CARDLYTICS COM 14161W105 0 -153 -100.00 0 -100.00
2022-08-12 2022-06-30 13F CARDLYTICS COM 14161W105 153 -211,636 -99.93 3 -99.97 0.0000
2022-05-13 2022-03-31 13F CARDLYTICS COM 14161W105 211,789 10,878 5.41 11,644 -12.31 0.0562
2022-02-14 2021-12-31 13F CARDLYTICS COM 14161W105 200,911 6,682 3.44 13,278 -18.55 0.0620
2021-11-12 2021-09-30 13F CARDLYTICS COM 14161W105 194,229 2,938 1.54 16,303 -32.85 0.0857
2021-08-10 2021-06-30 13F CARDLYTICS COM 14161W105 191,291 2,357 1.25 24,280 17.15 0.1368
2021-05-11 2021-03-31 13F CARDLYTICS COM 14161W105 188,934 -270 -0.14 20,726 -23.27 0.1403
2021-02-12 2020-12-31 13F CARDLYTICS COM 14161W105 189,204 -678 -0.36 27,012 101.60 0.2046
2020-11-13 2020-09-30 13F CARDLYTICS COM 14161W105 189,882 24,339 14.70 13,399 15.66 0.1255
2020-08-12 2020-06-30 13F CARDLYTICS COM 14161W105 165,543 13,728 9.04 11,585 118.30 0.1212
2020-05-12 2020-03-31 13F CARDLYTICS COM 14161W105 151,815 151,815 5,307 0.0696
2020-02-07 2019-12-31 13F CARDLYTICS COM 14161W105 0 -5,214 -100.00 0 -100.00
2019-11-12 2019-09-30 13F CARDLYTICS COM 14161W105 5,214 1,949 59.69 175 105.88 0.0024
2019-08-09 2019-06-30 13F CARDLYTICS COM 14161W105 3,265 3,265 85 0.0012
2019-02-12 2018-12-31 13F Cardlytics Common 14161W105 0 -9,231 -100.00 0 -100.00
2018-11-02 2018-09-30 13F Cardlytics Common 14161W105 9,231 9,231 231 0.0035
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.